Item Type No Grouping

Article

Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model. (2023) Perezimor Etifa, César Rodríguez, Céline Harmanus, Ingrid M. J. G. Sanders, Igor A. Sidorov, Olufunmilayo A. Mohammed, Emily Savage, Andrew R. Timms, Jane Freeman, Wiep Klaas Smits, Mark H. Wilcox and Simon D. Baines

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model. (2014) Grace S. Crowther, Caroline H. Chilton, Sharie L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines and Mark H. Wilcox

Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota. (2014) Grace S. Crowther, Caroline H. Chilton, Sharie L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines and Mark H. Wilcox

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease. (2013) David W. Eyre, A. Sarah Walker, Jane Freeman, Simon D. Baines, Warren N. Fawley, Caroline H. Chilton, David Griffiths, Alison Vaughan, Derrick W. Crook, Tim E. A. Peto and Mark H. Wilcox

Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model. (2013) Simon D. Baines, Caroline H. Chilton, Grace S. Crowther, Sharie L. Todhunter, Jane Freeman and Mark H. Wilcox

Mixed infection by Clostridium difficile in an in vitro model of the human gut. (2013) Simon D. Baines, Grace S. Crowther, Sharie L. Todhunter, Jane Freeman, Caroline H. Chilton, Warren N. Fawley and Mark H. Wilcox

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model. (2008) Simon D. Baines, Rachael O'Connor, Katie Saxton, Jane Freeman and Mark H. Wilcox

In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin. (2008) Rachael O'Connor, Simon D. Baines, Jane Freeman and Mark H. Wilcox

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. (2007) Jane Freeman, Simon D. Baines, Katie Saxton and Mark H. Wilcox

Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model. (2006) Simon D. Baines, Katie Saxton, Jane Freeman and Mark H. Wilcox

Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital. (2005) Jane Freeman, Joanna Stott, Simon D. Baines, Warren N. Fawley and Mark H. Wilcox

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. (2005) Jane Freeman, Simon D. Baines, Daniela Jabes and Mark H. Wilcox

Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model. (2005) Simon D. Baines, Jane Freeman and Mark H. Wilcox